MedPath

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE

WASHINGTON UNIVERSITY SCHOOL OF MEDICINE logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1891-01-01
Employees
10K
Market Cap
-
Website
http://www.medschool.wustl.edu

Minimal Residual Disease in Peripheral T-cell Lymphoma

Completed
Conditions
Peripheral T Cell Lymphoma
Interventions
Procedure: Tumor biopsy
Procedure: Peripheral blood draw
Procedure: Lymphotrack TCR clonality assay
First Posted Date
2017-09-29
Last Posted Date
2024-05-16
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
44
Registration Number
NCT03297697
Locations
🇺🇸

Memorial Sloan Kettering Cancer Center, New York, New York, United States

🇺🇸

Dana Farber Cancer Institute, Boston, Massachusetts, United States

🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Diffusion MRI in Cervical Spondylotic Myelopathy (CSM)

Active, not recruiting
Conditions
Cervical Spondylotic Myelopathy
Interventions
Diagnostic Test: MRI with DBSI technology
First Posted Date
2017-09-28
Last Posted Date
2024-10-21
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
71
Registration Number
NCT03296592
Locations
🇺🇸

Washington University, St. Louis, Missouri, United States

Postoperative Delirium: EEG Markers of Sleep and Wakefulness

Active, not recruiting
Conditions
Postoperative Delirium
First Posted Date
2017-09-25
Last Posted Date
2023-11-29
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
220
Registration Number
NCT03291626
Locations
🇺🇸

Barnes-Jewish Hospital/Washington University in St. Louis School of Medicine, Saint Louis, Missouri, United States

MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast Cancer

Phase 1
Withdrawn
Conditions
Breast Cancer
Cancer of Breast
Interventions
Biological: MCS110
Drug: Doxorubicin
Drug: Cyclophosphamide
Drug: Paclitaxel
Procedure: Bone marrow aspirate
Procedure: Peripheral blood samples
Procedure: Tumor tissue
First Posted Date
2017-09-18
Last Posted Date
2018-08-16
Lead Sponsor
Washington University School of Medicine
Registration Number
NCT03285607

Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies

Phase 2
Completed
Conditions
Depressive Disorder, Treatment-Resistant
Depressive Disorder, Major
Interventions
Drug: Nitrous Oxide 25%
Drug: Nitrous Oxide 50%
Drug: Placebo Gas
First Posted Date
2017-09-14
Last Posted Date
2022-04-04
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
24
Registration Number
NCT03283670
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Impact of Component Design and Fixation in Total Knee Arthroplasty

Completed
Conditions
Arthroplasties, Knee Replacement
Interventions
Device: Depuy total knee implant
Device: Triathlon total knee implant
First Posted Date
2017-09-05
Last Posted Date
2021-12-01
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
100
Registration Number
NCT03272178
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Remediation of Age-related Cognitive Decline: Vortioxetine and Cognitive Training

Phase 4
Completed
Conditions
Age-related Cognitive Decline
Interventions
Drug: Vortioxetine 10 mg
Behavioral: Cognitive training program
First Posted Date
2017-09-05
Last Posted Date
2020-01-14
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
129
Registration Number
NCT03272711
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Effect of Weight Loss on Body Composition and Metabolic Function in Women With Lipedema

Not Applicable
Active, not recruiting
Conditions
Lipedema
Metabolism
Interventions
Dietary Supplement: Weight loss
First Posted Date
2017-09-01
Last Posted Date
2023-12-19
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
20
Registration Number
NCT03271034
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Neoadjuvant Avelumab and Hypofractionated Proton Radiation Therapy Followed by Surgery for Recurrent Radiation-refractory Meningioma

Phase 1
Terminated
Conditions
Meningioma
Meningioma, Adult
Interventions
Drug: Avelumab
Radiation: Proton Therapy
Procedure: Surgery
First Posted Date
2017-08-30
Last Posted Date
2023-06-15
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
9
Registration Number
NCT03267836
Locations
🇺🇸

Washington University School of Medicine, Saint Louis, Missouri, United States

Palliative Care in the ICU

Not Applicable
Completed
Conditions
Palliative Care
Interventions
Other: Palliative Care
First Posted Date
2017-08-28
Last Posted Date
2019-01-24
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
242
Registration Number
NCT03263143
Locations
🇺🇸

Barnes Jewish Hospital, Saint Louis, Missouri, United States

© Copyright 2025. All Rights Reserved by MedPath